第七 单元 免疫变态反应结缔组织病Seventh unit immunity allergy connective tissue disease.docx
- 文档编号:28818190
- 上传时间:2023-07-19
- 格式:DOCX
- 页数:5
- 大小:18.53KB
第七 单元 免疫变态反应结缔组织病Seventh unit immunity allergy connective tissue disease.docx
《第七 单元 免疫变态反应结缔组织病Seventh unit immunity allergy connective tissue disease.docx》由会员分享,可在线阅读,更多相关《第七 单元 免疫变态反应结缔组织病Seventh unit immunity allergy connective tissue disease.docx(5页珍藏版)》请在冰豆网上搜索。
第七单元免疫变态反应结缔组织病Seventhunitimmunityallergyconnectivetissuedisease
第七单元免疫、变态反应、结缔组织病(Seventhunitimmunity,allergy,connectivetissuedisease)
第七单元免疫、变态反应、结缔组织病(Seventhunitimmunity,allergy,connectivetissuedisease)第七单元免疫、变态反应、结缔组织病(Seventhunitimmunity,allergy,connectivetissuedisease)Unitseventh,immunity,allergy,connectivetissuedisease.Txtyoucannotmakeeveryonesatisfied,becausenotallpeoplearepeople,successfulpeopleareinawaycattleB,roaderectiondoyouthinkIwillwatchyoudie?
Iwillclosemyeyeswiththeseventhunitofimmunity,allergy,connectivetissuediseaseSection1CharacteristicsofpediatricimmunesystemSpecificcellularimmunity(Tcellimmunity)(I)thymus:
thymusisthecentralimmuneorgan,andlymphoidstemcellsdifferentiateintomatureTcells(CD3positive,CD4orCD8singlepositive)sites.(two)Tcells:
thefunctionofCD4+Tcellsistomodulateimmuneresponses,calledhelperTcells(TH).CD8+cellsfunctionascytotoxicantigens,termedcytotoxicTcells.(three)cytokines:
avarietyofcytokinescanbeproducedintheprocessofimmuneresponse.TH1cellssecreteinterferongamma,interleukin-2,andTH2cellssecreteinterleukin-4,5,6,8,and9.Two,specifichumoralimmunity(Bcellimmunity)
(1)bonemarrowandlymphnodes:
thebonemarrowisthematuresiteofBcellsandfunctionsasacapsule.(two)Bcells:
comparedwithTcellimmunity,Bcellsdevelopslowly.(three)immunoglobulin:
theimmunoglobulinwithantibodyactivityiscalledimmunoglobulin.1.IgG:
throughtheplacenta,therearefoursubclasses,withthehighestproportionofIgG1.IgG1targetsproteinantigens,antibodies,andIgG2againstpolysaccharideantigenantibodies,andIgG4isassociatedwithallergies.2.IgM:
notthroughtheplacenta,IgMhighatbirth,needtofurtherdetectspecificantibodies,clearwhetherthepresenceofintrauterineinfection.Earlyadultlevel.3.lgA:
highlgAincordbloodsuggestsintrauterineinfectionandlocalantiinfectionofsecretorylgAmucosa.4.lgD(5yearsofage,adult20%)andlgE(7yearsofage)aredifficulttopassthroughtheplacenta.Three、nonspecificimmunityPhagocytosis:
largemononuclearcellsandneutrophilsarethemajorphagocyticcellsincirculation.(two)complementsystem:
reachedadultlevelin6~12months.SecondsectionbronchialasthmaBronchialasthmaisachronicinflammatorydiseaseoftheairways,whichisinvolvedinavarietyofcells,especiallymastcellsandeosinophilsandTlymphocytes,andishighlyreactivetotheairways.I.diagnosis(emphasis)
(1)infantasthmadiagnosticcriteria:
age3years.1.morethan3timesofwheezing3points2.lungwheezing2points3.wheezingsymptoms,suddenattack1points4.,otherspecifichistoryof15.ofoneortworelativeshaveasthma1pointsStandardforevaluation:
totalscoremorethan5pointsforthediagnosisofinfantasthma;suchaslungwheezedothefollowingtests:
(1)1gofepinephrine,each0.01mg/kgsubcutaneousinjection,15~20minuteslater,ifwheezingrelieforwheezingsignificantlyreduced,plus2points;IItosalbutamolaerosoloritswatersolutionafterinhalation,observethewheezingwheezingorchanges,suchasreducedobviouslycanbe2points.(two)diagnosisofasthmainchildrenover3yearsold1.asthmaisrecurrent(ormaybetracedtosomeallergenorirritationfactor)2.episodesofwheezingoccurinthelungs3.,antiasthmaticdrugseffective.Suspectedcasesgive1perthousandper0.01mg/kgsubcutaneousinjectionofepinephrine,orsalbutamolaerosolinhalationoritswatersolutionafter15minutesifasthmaremissionorwheezedecreasedishelpfultothediagnosisof.(three)diagnosticcriteriaofcoughvariantasthma1.coughcontinuedorrepeatedattacks1months,oftenaccompaniedbynocturnalorearlymorningparoxysmalcough,lesssputum,increasedafterexercise.2.,noclinicalsymptomsofinfection,orlong-termantibiotictreatmentinvalid.3.bronchodilatorcanrelievecoughonset(thebasicconditionforthediagnosisofthisdisease)4.haveallergiestoindividualsorfamilies,Airwayreactivitytestandallergendetectioncanbeusedasauxiliarydiagnosis.Two,treatment
(1)removalofthecauseofdisease(two)controlseizure;1.bronchodilator
(1)Adrenomimeticdrugs:
drugscommonlyusedinthesalbutamol(ShuChuanling);theterbutaline(ShuChuanningandBricasol);KleTero(clenbuterol).Inhalationtherapyisthefirstchoice.
(2)theophyllinedrugs:
aminophylline,sustained-releasetheophylline.(3)anticholinergicagents:
ipratropiumbromide.2.glucocorticoids:
thefirstchoiceforthetreatmentofasthma.
(1):
inhalationofbeclomethasone,budesonide.
(2)oralmedication:
short-termtreatmentofpatientswithmoreseverecondition.3.antibiotics:
usewithrespiratorytractbacterialinfections.(three)treatmentofpersistentstatusofasthma;1.oxygeninhalation:
oxygenconcentrationof40%,maintainPaO270~90mmHg.2.rehydrationandcorrectionofacidosis:
supplement1/5sodicsolutionwithsodiumbicarbonate,correctacidosis.3.glucocorticoiddrugs:
intravenoushydrocortisoneormethylprednisolone.4.bronchodilator:
1.Inhalationofsalbutamolaerosol1timesevery1~2hours;aminophyllineintravenousdrip;theabovetreatmentisnotgood,canbeinjectedintravenouslywithsalbutamol.5.isoproterenol:
theabovetreatmentisinvalid,try0.1g/kgperminuteintravenousdrip.6.sedatives:
chloralhydrateenema.7.:
thepersistentrespiratorymechanicalbreathingdifficulties;thedecreasedbreathsounds,thenwheezedisappeared;therespiratorymusclefatigueandthethoracicactivityislimited;thedisturbanceofconsciousness,andevencoma;theinhaled40%oxygenandcyanosisstillnoimprovement,PaCO2=65mmHg.Three,prevention(I)self-educationManagement:
(two)preventionofrecurrence1.immunotherapy
(1)desensitizationtherapy
(2)immunemodulationtreatment:
canusethymuspeptideandChinesetraditionalmedicinetowait.2.sodiumcitrate:
shouldbeinthefirst1monthsbeforetheonsetofgoodseasonbeganmedication.Ketotifen3.4.inhaledcorticosteroidaerosolcanrelieveasthmaticchildren,shouldcontinuetomaintaintheamountofinhalationfor6~24months.ThethirdsectionisacuterheumaticfeverHairageis5~15,andheartattackisthemostserious.Cancausepermanentheartvalvedisease.First,etiologyandpathogenesis:
AgroupBhemolyticstreptococcusinfectionaftertheimmuneresponse.Two,clinicalmanifestations(2,3,4,5)(I)generalperformanceAcuteonsetfeverat38~40degrees,abouthalfofthechildrenbeforetheonsetof1~4haveahistoryofupperrespiratorytractinfection.Lethargy,fatigue,anorexia,pale,sweating,nasalbleeding.(two)cardiacinflammation:
40to50%involvingtheheart,istheonlypersistentorgandamage.1.myocarditis:
tachycardia,heartenlargement,heartfailure,electrocardiogramisthemostcommononedegreeatrioventricularblock.2.endocarditis:
majorinvasionofthemitralvalveand/oraorticvalve.3.pericarditis:
pericardialeffusion,pericarditisisusuallyfullofinflammation.(three)arthritis:
seenin50to60%patients,mostlymigratoryarthritis,mainlyknee,ankle,elbowandwristjoints.Nodeformityofjoint.(four)dancingsickness:
3~7%.Thecourseofdiseaseisabout1~3months.(five)skinsymptoms;1.subcutaneousnodules:
in5%ofrheumaticfeverchildren,oftenaccompaniedbycardiacinflammation.2.ringerythema:
rare.Three.DiagnosticcriteriaThediagnosticcriteriaofJonesinclude3parts:
mainmanifestations;secondarymanifestations;evidenceofstreptococcalinfection.Inthepresenceofstreptococcalinfection,therearetwomainmanifestations,oramajormanifestationandtwosecondarymanifestations,afterexcludingotherdiseasescanbediagnosed.Four,treatmentandPrevention
(1)rest:
8peoplewhohavenoheartattackstayinbedfor2weeks;thepatientswithcardiacinflammationstayinbedfor4weeks;thepatientswithheartfailurestayinbedfortwoweeks.(two)eliminationofstreptococcalinfection:
penicillinfor2weeks.(three)winddampheattreatment:
1.aspirin:
withoutcardiacinflammation,use80to100mg/kgeveryday,4~8weeks.2.glucocorticoids:
Patientswithcardiacinflammationweretreatedwithprednisonedaily2mg/kg,8~12weeks.(four)thetreatmentofcongestiveheartfailure:
largedosemethylprednisolone,10to30mg/kgperday,for1~3days.Carefuluseofdigitalis.(five)thetreatmentofchorea:
canusephenobarbital,valiumandothersedative.(six)prevention:
long-actingpenicillin1million200thousandunits,1timesamonthintramuscularinjection,atleast5years.Exercises1.,thehighestproportionofIgGsubclassesintheserumis(A)A.IgG1B.IgG2C.IgG3D.IgG4E.IgG5[answernumber:
21070101]What2.Th1cellsproduceis(answer:
A)A.interleukin2B.interleukin4C.interleukin5D.interleukin6E.interleukin8[answernumber:
21070102]3.doesnotmeetthecoughvariantasthmacharacteristic(answer:
C)A.coughsrepeatedlyfor1monthsB.coughaggravatedafterexerciseC.phlegmD.hasnofeverCoughrelievingE.afterinhalationofsalbutamol[answernumber:
21070103]4.thetreatmentofasthmastatusiscorrect(answer:
B)A.inhalationofsodiumcitrateB.glucocorticoidintravenousdripC.oralpropranololD.highdosegammaglobulinE.applicationofdigitalisyellow[answernumber:
21070104]5.theorganofcontinuousrheumaticfeverinjuryis(answer:
D)A.jointdeformityB.renalfailureC.coronaryarteryaneurysmD.heartvalvediseaseE.pulmonaryfibrosis[answernumber:
21070105]6.themostcommonelectrocardiographicchangeinrheumaticfeveris(answer:
D)A.ventricularprematurecontractionProlongationofB.QTintervalC.therightatriumislargeD.d
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 第七 单元 免疫变态反应结缔组织病Seventh unit immunity allergy connective tissue disease 免疫 变态反应 结缔组织 Seventh
链接地址:https://www.bdocx.com/doc/28818190.html